白癬治療の世界市場レポート 2025年

白癬治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.6％で151億4,000万米ドルに成長します。予測期間における成長の背景には、併用療法に対する需要の高まり、糖尿病やその他の免疫抑制疾患の有病率の上昇、皮膚科治療における遠隔医療の拡大、新規抗真菌化合物に関する研究の進展、天然抗真菌剤やハーブ抗真菌剤に対する消費者の嗜好の高まりなどがあります。主な動向としては、ナノテクノロジーに基づく抗真菌治療の開発、真菌感染診断における人工知能の利用拡大、処方箋に基づく抗真菌治療に対する需要の高まり、消費者直販の抗真菌ブランドの拡大、スキンケア製品への抗真菌治療の統合の拡大などが挙げられます。

真菌感染症の有病率の増加は、白癬治療市場の成長を牽引すると予想されます。真菌感染症は、真菌が過剰に増殖したり体内に侵入したりすることで発生し、様々な臓器や組織に影響を及ぼします。このような感染症の増加は、免疫抑制治療の増加、地球温暖化、免疫システムが低下した人口の増加などの要因に起因しています。白癬治療は、真菌感染症の管理において、特に感染しやすい人々の感染拡大を防ぎ、合併症を減らし、感染率をコントロールする効果的な抗真菌療法を提供することで、重要な役割を果たしています。例えば、2024年11月、英国の政府機関であるUK Health Security Agency（UKHSA）は、2022年の英国におけるイースト菌による血流感染症が前年比4％増加したことを報告し、真菌関連の健康問題の増加傾向を浮き彫りにしました。さらに、米国を拠点とする非営利団体である国際感染症学会は2024年9月、侵襲性真菌感染症が世界で年間650万件の割合で発生し、約380万人が死亡、うち250万人がこれらの感染症に直接起因すると推定しています。毎年210万人以上が侵襲性アスペルギルス症を発症しています。その結果、真菌感染症の発生率の増加が白癬治療市場の拡大に拍車をかけています。

また、ヘルスケア施設の高度化も白癬治療市場の成長に寄与すると期待されています。病院、クリニック、診断センターなどのヘルスケア施設は、さまざまな症状の診断や治療に不可欠な医療サービスを提供しています。ヘルスケアインフラの改善、患者中心のケアへの注力、人口増加、高齢化により、これらの施設の強化が進んでいます。白癬治療を利用できるようになったことで、専門的な皮膚科治療が促進され、真菌感染症に関する患者教育が進み、利用しやすく効果的な治療法の導入が促進されるなど、ヘルスケアの向上がサポートされています。このような取り組みは、ヘルスケアシステムが皮膚関連疾患をより効率的に管理する能力を拡大し、公衆衛生の向上につながっています。例えば2023年5月、米国の非営利団体である米国医療協会は、米国の病院数が前年の6,093から6,129に増加したと報告しました。このようなヘルスケアインフラの向上が、白癬治療市場の拡大をさらに後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界白癬治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の白癬治療市場：成長率分析
• 世界の白癬治療市場の実績：規模と成長, 2019-2024
• 世界の白癬治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界白癬治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の白癬治療市場薬物クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗真菌薬
• 併用薬
• 世界の白癬治療市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 体部白癬
• 足白癬
• 股部白癬
• 頭部白癬
• 白癬菌
• その他の治療の種類
• 世界の白癬治療市場投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• トピック
• オーラル
• 非経口
• 世界の白癬治療市場流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の白癬治療市場抗真菌薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所抗真菌薬
• 経口抗真菌薬
• 抗真菌シャンプー
• 世界の白癬治療市場、複合薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗真菌薬とステロイドの組み合わせ
• 抗真菌剤と消毒剤の組み合わせ

第7章 地域別・国別分析

• 世界の白癬治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の白癬治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 白癬治療市場：競合情勢
• 白癬治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi-Aventis Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• GlaxoSmithKline Plc（GSK）
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Perrigo Company plc
• Aurobindo Pharma Ltd.
• Dr Reddy's Laboratories Ltd.
• Cipla Ltd.
• Intas Pharmaceuticals Ltd.
• Zydus Group
• Glenmark Pharmaceuticals Inc.
• Biocon Limited
• Torrent Pharmaceuticals Ltd.
• Taro Pharmaceutical Industries Ltd.
• Enzon Pharmaceuticals

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 白癬治療市場2029：新たな機会を提供する国
• 白癬治療市場2029：新たな機会を提供するセグメント
• 白癬治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Ringworm treatment involves the use of medications to eliminate the fungal infection caused by dermatophytes, relieve symptoms such as itching and redness, and prevent the spread of the contagious condition to other body areas or individuals. Along with medication, maintaining proper hygiene, keeping affected areas dry, and avoiding direct contact with infected individuals or surfaces help manage and prevent the recurrence of ringworm infections.

The primary drug classes for ringworm treatment include antifungals and combination drugs. Antifungals are designed to prevent, control, or eliminate fungal infections by targeting fungal cells while minimizing harm to the host. Treatment options address various types of ringworm, such as tinea corporis, tinea pedis, tinea cruris, tinea capitis, and tinea manuum, with administration routes including topical, oral, and parenteral. These treatments are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The ringworm treatment market research report is one of a series of new reports from The Business Research Company that provides ringworm treatment market statistics, including ringworm treatment industry global market size, regional shares, competitors with a ringworm treatment market share, detailed ringworm treatment market segments, market trends and opportunities, and any further data you may need to thrive in the ringworm treatment industry. This ringworm treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ringworm treatment market size has grown strongly in recent years. It will grow from $11.50 billion in 2024 to $12.17 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth during the historic period can be attributed to the increasing prevalence of fungal infections, greater awareness of hygiene and personal care, the growing availability of over-the-counter antifungal medications, the rising adoption of topical antifungal treatments, and the increasing incidence of immunocompromised conditions.

The ringworm treatment market size is expected to see strong growth in the next few years. It will grow to $15.14 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to the increasing demand for combination therapies, the rising prevalence of diabetes and other immunosuppressive conditions, the expansion of telemedicine for dermatological treatments, growing research on novel antifungal compounds, and the rising consumer preference for natural and herbal antifungal products. Major trends include the development of nanotechnology-based antifungal treatments, the increasing use of artificial intelligence in fungal infection diagnosis, the rising demand for prescription-based antifungal therapies, the expansion of direct-to-consumer antifungal brands, and the growing integration of antifungal treatments in skincare products.

The increasing prevalence of fungal infections is expected to drive the growth of the ringworm treatment market. Fungal infections occur when fungi overgrow or invade the body, affecting various organs and tissues. The rise in these infections is attributed to factors such as increased use of immunosuppressive treatments, global warming, and a growing population with compromised immune systems. Ringworm treatment plays a crucial role in managing fungal infections by providing effective antifungal therapies that prevent spread, reduce complications, and control infection rates, particularly in vulnerable populations. For instance, in November 2024, the UK Health Security Agency (UKHSA), a UK-based government agency, reported a 4% rise in bloodstream infections caused by yeast in England in 2022 compared to the previous year, highlighting an upward trend in fungal-related health issues. Additionally, in September 2024, the International Society for Infectious Diseases, a US-based nonprofit organization, estimated that invasive fungal infections occur at an annual rate of 6.5 million cases globally, leading to approximately 3.8 million deaths, with 2.5 million directly attributed to these infections. Over 2.1 million people develop invasive aspergillosis each year. As a result, the increasing incidence of fungal infections is fueling the expansion of the ringworm treatment market.

The advancement of healthcare facilities is also expected to contribute to the growth of the ringworm treatment market. Healthcare facilities, including hospitals, clinics, and diagnostic centers, provide essential medical services for diagnosing and treating various conditions. Improvements in healthcare infrastructure, a focus on patient-centered care, population growth, and an aging demographic have driven enhancements in these facilities. The availability of ringworm treatment has supported healthcare improvements by fostering specialized dermatological care, increasing patient education on fungal infections, and promoting the adoption of accessible, effective treatment options. These efforts help healthcare systems expand their ability to manage skin-related diseases more efficiently, leading to improved public health outcomes. For example, in May 2023, the American Health Care Association, a US-based nonprofit organization, reported that the number of hospitals in the United States increased from 6,093 in the previous year to 6,129, reflecting a 0.591% growth. This improvement in healthcare infrastructure is further driving the expansion of the ringworm treatment market.

Companies in the ringworm treatment market are focusing on developing innovative solutions, such as full-cycle skin infection control formulations, to enhance treatment effectiveness and prevent recurrence. A full-cycle skin infection control formulation is designed to target all stages of a skin infection, from eliminating the pathogen to preventing recurrence, soothing inflammation, and promoting skin healing. For instance, in May 2022, Bayer AG, a Germany-based pharmaceutical company, launched an improved version of Canesten, an antifungal brand. The updated Canesten product line features an advanced formulation designed to provide faster relief from fungal infections while being gentle on the skin. The relaunch emphasizes a full-cycle treatment approach by combining antifungal, anti-inflammatory, and skin-soothing properties in a single product, ensuring not only effective infection control but also long-term prevention of recurrence. These innovations are shaping the future of the ringworm treatment market by providing more comprehensive and patient-friendly solutions.

Major players in the ringworm treatment market are Pfizer Inc., Merck & Co. Inc., Bayer Healthcare, Sanofi-Aventis, Abbott Laboratories, Novartis AG, GlaxoSmithKline Plc (GSK), Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Aurobindo Pharma Ltd., Dr Reddy's Laboratories Ltd., Cipla Ltd., Intas Pharmaceuticals Ltd., Zydus Group, Glenmark Pharmaceuticals Inc., Biocon Limited, Torrent Pharmaceuticals Ltd., Taro Pharmaceutical Industries Ltd., Enzon Pharmaceuticals.

North America was the largest region in the ringworm treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ringworm treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ringworm treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ringworm treatment market consists of sales of adjunctive treatment, azoles, and allylamines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ringworm Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ringworm treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ringworm treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ringworm treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Classes: Antifungals; Combination Drugs
• 2) By Treatment Types: Tinea Corpois; Tinea Pedis; Tinea Cruris; Tinea Capitis; Tinea Manuum; Other Treatment Types
• 3) By Route Of Administrations: Topical; Oral; Parenteral
• 4) By Distribution Channels: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Antifungals: Topical Antifungals; Oral Antifungals; Antifungal Shampoos
• 2) By Combination Drugs: Antifungal Plus Steroid Combinations; Antifungal Plus Antiseptic Combinations
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Bayer Healthcare; Sanofi-Aventis; Abbott Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ringworm Treatment Market Characteristics

3. Ringworm Treatment Market Trends And Strategies

4. Ringworm Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Ringworm Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Ringworm Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Ringworm Treatment Market Growth Rate Analysis
• 5.4. Global Ringworm Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Ringworm Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Ringworm Treatment Total Addressable Market (TAM)

6. Ringworm Treatment Market Segmentation

• 6.1. Global Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antifungals
• Combination Drugs
• 6.2. Global Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tinea Corpois
• Tinea Pedis
• Tinea Cruris
• Tinea Capitis
• Tinea Manuum
• Other Treatment Types
• 6.3. Global Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical
• Oral
• Parenteral
• 6.4. Global Ringworm Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Ringworm Treatment Market, Sub-Segmentation Of Antifungals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Antifungals
• Oral Antifungals
• Antifungal Shampoos
• 6.6. Global Ringworm Treatment Market, Sub-Segmentation Of Combination Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antifungal Plus Steroid Combinations
• Antifungal Plus Antiseptic Combinations

7. Ringworm Treatment Market Regional And Country Analysis

• 7.1. Global Ringworm Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Ringworm Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ringworm Treatment Market

• 8.1. Asia-Pacific Ringworm Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ringworm Treatment Market

• 9.1. China Ringworm Treatment Market Overview
• 9.2. China Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ringworm Treatment Market

• 10.1. India Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ringworm Treatment Market

• 11.1. Japan Ringworm Treatment Market Overview
• 11.2. Japan Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ringworm Treatment Market

• 12.1. Australia Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ringworm Treatment Market

• 13.1. Indonesia Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ringworm Treatment Market

• 14.1. South Korea Ringworm Treatment Market Overview
• 14.2. South Korea Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ringworm Treatment Market

• 15.1. Western Europe Ringworm Treatment Market Overview
• 15.2. Western Europe Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ringworm Treatment Market

• 16.1. UK Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ringworm Treatment Market

• 17.1. Germany Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ringworm Treatment Market

• 18.1. France Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ringworm Treatment Market

• 19.1. Italy Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ringworm Treatment Market

• 20.1. Spain Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ringworm Treatment Market

• 21.1. Eastern Europe Ringworm Treatment Market Overview
• 21.2. Eastern Europe Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ringworm Treatment Market

• 22.1. Russia Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ringworm Treatment Market

• 23.1. North America Ringworm Treatment Market Overview
• 23.2. North America Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ringworm Treatment Market

• 24.1. USA Ringworm Treatment Market Overview
• 24.2. USA Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ringworm Treatment Market

• 25.1. Canada Ringworm Treatment Market Overview
• 25.2. Canada Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ringworm Treatment Market

• 26.1. South America Ringworm Treatment Market Overview
• 26.2. South America Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ringworm Treatment Market

• 27.1. Brazil Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ringworm Treatment Market

• 28.1. Middle East Ringworm Treatment Market Overview
• 28.2. Middle East Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ringworm Treatment Market

• 29.1. Africa Ringworm Treatment Market Overview
• 29.2. Africa Ringworm Treatment Market, Segmentation By Drug Classes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Ringworm Treatment Market, Segmentation By Treatment Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Ringworm Treatment Market, Segmentation By Route Of Administrations, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ringworm Treatment Market Competitive Landscape And Company Profiles

• 30.1. Ringworm Treatment Market Competitive Landscape
• 30.2. Ringworm Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi-Aventis Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Ringworm Treatment Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. GlaxoSmithKline Plc (GSK)
• 31.3. Teva Pharmaceutical Industries Ltd.
• 31.4. Sun Pharmaceutical Industries Ltd.
• 31.5. Perrigo Company plc
• 31.6. Aurobindo Pharma Ltd.
• 31.7. Dr Reddy's Laboratories Ltd.
• 31.8. Cipla Ltd.
• 31.9. Intas Pharmaceuticals Ltd.
• 31.10. Zydus Group
• 31.11. Glenmark Pharmaceuticals Inc.
• 31.12. Biocon Limited
• 31.13. Torrent Pharmaceuticals Ltd.
• 31.14. Taro Pharmaceutical Industries Ltd.
• 31.15. Enzon Pharmaceuticals

32. Global Ringworm Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ringworm Treatment Market

34. Recent Developments In The Ringworm Treatment Market

35. Ringworm Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Ringworm Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Ringworm Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Ringworm Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer